Radiance Biopharma to Participate in 2025 BIO CEO & Investor Conference
NEW YORK, NY, UNITED STATES, February 10, 2025 /EINPresswire.com/ -- Radiance Biopharma, a biotechnology company developing next generation Antibody Drug Conjugates (ADCs), announced it will attend and schedule meetings at the 2025 BIO CEO & Investor …